Alterity Therapeutics (PRNAD) Treasury Shares (2010 - 2011)
Alterity Therapeutics (PRNAD) posted quarterly Treasury Shares of $292.3 million for Q2 2011, up 41.26% year-over-year from $206.9 million in Q2 2010, and up 41.26% on a QoQ basis from $206.9 million in Q2 2010.
Alterity Therapeutics (PRNAD) Treasury Shares (2010 - 2011) Analysis & Trends
Alterity Therapeutics (PRNAD) has reported Treasury Shares for 2 consecutive years, with $292.3 million the latest figure, recorded in Q2 2011.
- In Q2 2011, Treasury Shares rose 41.26% year-over-year to $292.3 million; the TTM figure through Jun 2011 stood at $292.3 million (up 41.26% YoY), while the FY2011 annual figure was $292.3 million, up 41.26% from the prior year.
- Treasury Shares came in at $292.3 million for Q2 2011 at Alterity Therapeutics, up from $206.9 million in the prior quarter.
- The five-year high for Treasury Shares was $292.3 million in Q2 2011, with the low at $206.9 million in Q2 2010.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 292.27 Mn |
| Jun 30, 2011 | 292.27 Mn |
| Jun 30, 2010 | 206.91 Mn |
| Jun 30, 2010 | 206.91 Mn |